Justin Lindemann, MBChB MBA
AstraZeneca
2
0
1
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Richard Baird, MD PhD FRCP
Breast Cancer Research Unit, University of Cambridge
Shared therapeutic areas:
Worked with same sponsors:
Justin Lindemann
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Erika Hamilton
Nashville Hospital, United States
Shared therapeutic areas:
Worked with same sponsors:
Hung T Khong, MD
University of Utah
Shared therapeutic areas:
François-Clément Bidard
Institut Curie
Shared therapeutic areas:
Wei Li, M.D.
The First Hospital of Jilin University
Shared therapeutic areas:
Yusha Zhu, MD PhD
Kind Pharmaceuticals LLC
Shared therapeutic areas:
Sibylle Loibl, MD, PhD
Prof., MD ASCO, ESGO, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Faculty Member, SABCS Faculty member
Shared therapeutic areas:
Richard Baird, MD, PhD
Cambridge University Hospitals
Shared therapeutic areas:
Worked with same sponsors:
Martine Piccart, Md, PhD
Jules Bordet Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
All 2 trials loaded